Fischer Medical Ventures Ltd — Updates, 11-08-2025: Company Update

Fischer Medical Ventures' monitoring agency report confirms the utilization of funds from its preferential issue. The company has raised Rs. 270.40 crore from equity shares and warrants, and these proceeds have been deployed as planned, with no deviations from the stated objects. A significant portion, Rs. 250.41 crore, has been allocated for growth objectives, specifically for investments in wholly-owned subsidiaries to expand in imaging technologies and preventive healthcare. Additionally, Rs. 19.99 crore was used for general corporate purposes, including a loan repayment. This indicates the company is on track with its fund utilization strategy, providing clarity to investors.